92
Participants
Start Date
December 21, 2020
Primary Completion Date
September 18, 2024
Study Completion Date
December 18, 2024
Analgesia via epidural catheter
Ropivacain-infusion 2 mg/ml 1,25ml/h/10kg IBW (ideal body weight) is started to patients in the beginning of the surgery and is continued to POD 4. The rest of the treatment obey study protocol in both groups.
Analgesia via wound catheter
Ropivacain 5 mg/ml 2,5ml/10kg IBW (ideal body weight) is given to patients in the end of the surgery. After that ropivacain-infusion 2mg/ml 1,25ml/h/10kg IBW is started to patients and is continued to POD 4. The rest of the treatment obey study protocol in both groups.
Helsinki University Hospital, Helsinki
University of Helsinki
OTHER
Helsinki University Central Hospital
OTHER